Contact
Please use this form to send email to PR contact of this press release:
Neuralstem Announces Last Subject Enrolled in Phase 2 Trial with NSI-189 for Major Depressive Disorder
TO:
Please use this form to send email to PR contact of this press release:
Neuralstem Announces Last Subject Enrolled in Phase 2 Trial with NSI-189 for Major Depressive Disorder
TO: